Premium
P3‐343: AGE‐NORMED DIFFUSION BASIS SPECTRUM IMAGING (DBSI) CELL RATIOS TO ASSESS NEUROINFLAMMATION IN ALZHEIMER'S DISEASE CLINICAL TRIALS
Alzheimer's And DementiaPeer ReviewedCharil Arnaud +42018Journals
P3-343 AGE-NORMED DIFFUSION BASIS SPECTRUM IMAGING (DBSI) CELL RATIOS TO ASSESS NEUROINFLAMMATION IN ALZHEIMER’S DISEASE CLINICAL TRIALS Arnaud Charil, Qing Wang, Yong Wang, Tammie L. S. Benzinger, Adam J. Schwarz, Eli Lilly and Company, Indianapolis, IN, USA; Washington University School of Medicine, St. Louis, MO, USA; Washington University in St. Louis School of Medicine, St. Louis, MO, USA. Contact e-mail: arnaud.charil@lilly.com
This content is not available in your region!
Continue researching from Zendy home
Having issues? Contact support